Association of the Src homology 2 domain-containing inositol 5′ phosphatase (SHIP) to releasability in human basophils

Molecular Immunology

Volumn 38, Issue 16-18, 2002, Pages 1323-1327

  MacDonald, Susan M ^a   Vonakis, Becky M ^a  

^a JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

Human basophils; Human Recombinant Histamine Releasing Factor (HrHRF); Releasability; Src homology 2 domain containing 5 phosphatase (SHIP)

Indexed keywords

DEUTERIUM OXIDE; INTERLEUKIN 3; PHOSPHATASE; RELEASING FACTOR; SRC HOMOLOGY 2 DOMAIN CONTAINING INOSITOL 5' PHOSPHATASE; UNCLASSIFIED DRUG; INPPL1 PROTEIN, HUMAN; TRANSLATIONALLY CONTROLLED TUMOR PROTEIN, P23; TUMOR MARKER;

ALLERGY; ASTHMA; BASOPHIL; BONE MARROW; CONFERENCE PAPER; HISTAMINE RELEASE; HUMAN; MAST CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

BASOPHILS; HISTAMINE RELEASE; HUMANS; PHOSPHORIC MONOESTER HYDROLASES; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 0036034836     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(02)00082-2     Document Type: Conference Paper

References (57)

1. Anderson K.E., Coadwell J., Stephens L.R., Hawkins P.T. Translocation of PDK-1 to the plasma membrane is important in allowing PDK-1 to activate protein kinase B. Curr. Biol. 8:1998;684-691.
2. Bheekha-Escura R., Chance S.R., Langdon J.M., MacGlashan D.W. Jr., MacDonald S.M. Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor. J. Allergy Clin. Immunol. 103:1999;937-943.
3. Bheeka-Escura R., MacGlashan D.W. Jr., Langdon J.M., MacDonald S.M. The human recombinant histamine releasing factor (HrHRF) activates human eosinophils and the eosinophilic-like cell line, AML14-3D10. Blood. 96:2000;2191-2198.
4. Bohm H., Benndorf R., Gaestel M., Gross B., Nurnberg P., Kraft R., Otto A., Bielka H. The growth-related protein P23 of the Ehrlich ascites tumor: translational control, cloning and primary structure. Biochem. Int. 19:1989;277-286.
5. Brauweiler A.M., Tamir I., Cambier J.C. Bi-level control of B-cell activation by the inositol 5-phosphatase SHIP. Immunol. Rev. 176:2000;69-74.
6. Cantley L.C., Neel M. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3 kinase/AKT pathway. Proc. Natl. Acad. Sci. U.S.A. 96:1999;4240-4245.
7. Carver D.J., Aman M.J., Ravichandran K.S. SHIP inhibits Akt activation in B cells through regulation of Akt membrane localization. Blood. 96:2000;1449-1456.
8. Casolaro V., Galeone D., Giacummo A., Sanduzzi A., Melillo G., Marone G. Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and from bronchoalveolar lavage in asthmatics. Am. Rev. Respir. Dis. 139:1989;1375-1382.
9. Damen J.E., Liu L., Rosten P., Humphries R.K., Jefferson A.B., Majerus P.W., Krystal G. The 145 kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidyl inositol 3,4,5 trisphosphate 5-phosphatase. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1689-1693.
10. Findlay S.R., Lichtenstein L.M. Basophil "releasability" in patients with asthma. Am. Rev. Respir. Dis. 122:1980;53-59.
11. Huber M., Helgason C.D., Damen J.E., Liu L., Humphries R.K., Krystal G. The Src homology 2 containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc. Natl. Acad. Sci. U.S.A. 95:1998a;11330-11335.
12. Huber M., Helgason C.D., Scheid M.P., Duronio V., Humphries R.K., Krystal G. Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells. EMBO J. 24:1998b;7311-7319.
13. Huber, M., Helgason, C.D., Damen, J.E., Scheid, M., Duronio, V., Lam, V., Humphries, R.K., Krystal, G., 1999a. The role of SHIP in FcεRI-induced signaling. In: Daeron, M., Vivier, E. (Eds.), Current Topics in Microbiology and Immunology, Vol. 244. Springer, Berlin, pp. 29-41.
14. Huber, M., Helgason, C.D., Damen, J.E., Scheid, M.P., Duronio, V., Liu, L., Ware, M.D., Humphries, R.K., Krystal, G., 1999b. The role of SHIP in growth factor induced signaling. In: Pawson, A.J. (Ed.), Progress in Biophysics and Molecular Biology, Elsevier, The Netherlands, pp. 423-434.
15. Huber M., Hughes M.R., Krystal G. Thapsigargin-induced degranulation of mast cells is dependent on transient activation of phosphatidyl inositol 3 kinase. J. Immunol. 165:2000;124-133.
16. Kavanaugh W.M., Pot D.A., Chin S.M., Deuter-Reinhard M., Jefferson A.B., Norris F.A., Masiarz F.R., Cousens L.S., Majerus P.W., Williams L.T. Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2. Curr. Biol. 6:1996;438-445.
17. Kepley C.L., Wilson B.S., Oliver J.M. Identification of the FcεRI-activated tyrosine kinases Lyn, Syk, and Zap-70 in human basophils. J. Allergy Clin. Immunol. 102:1998;304-315.
18. Kepley C.L., Youssef L., Andrews R.P., Wilson B.S., Oliver J.M. Syk deficiency in non-releaser basophils. J. Allergy Clin. Immunol. 104:1999;279-284.
19. Kepley C.L., Cambier J.C., Morel P.A., Lujan D., Ortega E., Wilson B.S., Oliver J.M. Negative regulation of FcεRI signaling by FcγRII co-stimulation in human blood basophils. J. Allergy Clin. Immunol. 106:2000;337-348.
20. Kimura T., Sakamoto H., Apella E., Siriganian R. The negative signaling molecule SH2-domain containing inositol polyphosphate 5-phosphatase (SHIP) binds to the tyrosine-phosphorylated β subunit of the high affinity IgE receptor. J. Biol. Chem. 272:1997;13991-13991.
21. Kitaura J., Asai K., Maeda-Yamamoto M., Kawakami Y., Kikkawa U., Kawakami T. Akt-dependent cytokine production in mast cells. J. Exp. Med. 192:2000;729-739.
22. Krystal G. Lipid phosphatases in the immune system. Immunology. 12:2000;397-403.
23. Lavens-Phillips S., MacGlashan D.W. Jr. The role of p53/56lyn and p72syk in IgE-mediated signal transduction in human basophils. FASEB J. 12:1998;A591.
24. Lavens-Phillips S.E., MacGlashan D.W. Jr. The tyrosine kinases p53/56lyn and p72syk are differentially expressed at the protein level but not at the messenger RNA level in non-releasing human basophils. Am. J. Respir. Cell Mol. Biol. 23:2000;566-571.
25. Lichtenstein, L.M., Conroy, M.C., 1976. The "releasability" from human basophils and granulocytes. In: Mathov, E., Sindo, T., Naranjo, P. (Eds.), Allergy and Clinical Immunology. Excerpta Medica, Amsterdam, pp. 109-115.
26. Lioubin M.N., Algate P.A., Tsai S., Carlberg K., Aebersold A., Rohrschneider L.R. p150SHIP, a signal transduction molecule with inositol polyphosphate 5-phosphatase activity. Genes Dev. 10:1996;1084-1095.
27. Liu L., Damen J.E., Hughes M.R., Babic I., Jirik F.R., Krystal G. The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis. J. Biol. Chem. 272:1997;8983-8988.
28. MacDonald S.M., Schleimer R.P., Kagey-Sobotka A., Gillis S., Lichtenstein L.M. Recombinant IL-3 induces histamine release from human basophils. J. Immunol. 142:1989;3527-3532.
29. 2O sensitivity. Clin. Exp. Allergy. 21:1991;133-138.
30. MacDonald S.M., Rafnar T., Langdon J., Lichtenstein L.M. Molecular identification of an IgE-dependent histamine releasing factor. Science. 269:1995;688-690.
31. MacGlashan, D.W. Jr., Lavens-Phillips, S., Miura, K., 2000. Perspectives on the regulation of secretion from human basophils and mast cells. In: Mast Cells and Basophils. Chapter 13, Academic Press, New York, pp. 195-207.
32. Mano H. Tec family of protein-tyrosine kinases: an overview of their structure and function. Cytokine Growth Factor Rev. 10:1999;267.
33. Marone G., Casolaro V., Cirillo R., Stellato C., Genovese A. Pathophysiology of human basophils and mast cells in allergic disorders. Clin. Immunol. Immunopathol. 50:1989;S24-S40.
34. Marone G., Spadaro G., Patella V., Genovese A. The clinical relevance of basophil releasability. J. Allergy Clin. Immunol. 94:1994;1293-1303.
35. 4 release in human basophils. J. Allergy Clin. Immunol. 102:1998;512-520.
36. 4 generation, but not histamine release or IL-4 production from human basophils. J. Immunol. 162:1999;4198-4206.
37. Miura K., MacGlashan D.W. Jr. Expression of protein kinase C isozymes in human basophils: regulation by physiological and non-physiological stimuli. Blood. 92:1998;1206-1218.
38. 4 generation in human basophils: difference in characteristics between acute and late priming effects. J. Immunol. 164:2000a;3026-3034.
39. Miura K., MacGlashan D.W. Jr. Phosphatidyl inositol 3 kinase regulates p21ras activation during IgE-mediated stimulation of human basophils. Blood. 96:2000b;2199-2205.
40. 4 secretion following stimulation of human basophils with anti-IgE antibody. J. Immunol. 167:2001;7027-7037.
41. 2+ oscillatory response. J. Immunol. 161:1998;5129-5132.
42. Okazaki, H., Siraganian, R.P., 1999. Signal transduction for secretion in basophils. Allergy and Clinical Immunology International (11/3) 86-92.
43. Oliver J.M., Kepley C.L., Ortega E., Wilson B.S. Immunologically mediated signaling in basophils and mast cells: finding therapeutic targets for allergic diseases in the human FcεRI signaling pathway. Immunopharmacology. 48:2000;269-281.
44. Ono M.S., Bolland S., Tempst P., Ravetch J.V. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc-γ-RIIB. Nature. 383:1996;263.
45. Sanchez J.C., Schaller D., Ravier F., Golaz O., Jaccoud S., Belet M., Wilkins M.R., James R., Deshusses J., Hochstrasser D. Translationally controlled tumor protein: a protein identified in several non-tumoral cells including erythrocytes. Electrophoresis. 18:1997;150-155.
46. 3: a regulatory nexus between tyrosine kinases and sustained calcium signals. Cell. 94:1998;5-8.
47. 3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J. 17:1998;1961.
48. Schroeder J.T., Lichtenstein L.M., MacDonald S.M. An immunoglobulin E-dependent recombinant histamine releasing factor induces IL-4 secretion from human basophils. J. Exp. Med. 183:1996;1265-1270.
49. Schroeder J.T., Lichtenstein L.M., MacDonald S.M. Recombinant histamine-releasing factor enhances IgE dependent IL-4 and IL-13 secretion by human basophils. J. Immunol. 159:1997;447-452.
50. Tridandapani S., Chacko G.W., Brocklyn J.R., Coggeshall K.M. Negative signaling in B cells causes reduced ras activity by reducing Shc-Grb2 interactions. J. Immunol. 158:1997;1125-1132.
51. Tu Z., Ninos J.M., Ma Z., Wang J.-W., Lemos M.P., Desponts C., Ghansah T., Howson J.M., Kerr W.G. Embryonic and hematopoietic stem cells express a novel SH2-containing inositol 5′-phosphatase isoform that partners with the Grb2 adapter protein. Blood. 98:2001;2028-2038.
52. Turner H., Kinet J.-P. Signalling through the high-affinity IgE receptor FcεRI. Nature. 402:1999;B24-B30.
53. Voets T., Prenen J., Fleig A., Vennekens R., Watanabe H., Hoenderop J.G., Bindels R.J., Droogmans G., Penner R., Nilius B. CaT1 and the calcium release-activated calcium channel manifest distinct pore properties. J. Biol. Chem. 276:2001;47767-47770.
54. Vonakis B.M., Sora R., Langdon J.M., Casolaro V., MacDonald S.M. Inhibition of cytokine gene transcription by the human recombinant histamine releasing factor (HrHRF). J. Allergy Clin. Immunol. (AAAAI Abstract). 107(S60):2001a;206.
55. Vonakis B.M., Gibbons S., Sora R., Langdon J.M., MacDonald S.M. Src homology 2 domain-containing inositol 5′ phosphatase is negatively associated with histamine release to human recombinant histamine-releasing factor in human basophils. J. Allergy Clin. Immunol. 108:2001b;822-831.
56. Wantke F., MacGlashan D.W. Jr., Langdon J.M., MacDonald S.M. The human recombinant histamine releasing factor: functional evidence that it does not bind to the IgE molecule. J. Allergy Clin. Immunol. 103:1999;642-648.
57. Yue L., Peng J.B., Hediger M.A., Clapham D.E. CaT1 manifests the pore properties of the calcium-release-activated calcium channel. Nature. 410:2001;705-709.